"We were very impressed with the manner and speed in which SCM Pharma was able to deliver the fill/finish of our radiolabeled cytotoxic compound. The team showed great willingness to meet the tight deadline and was able to come up with solutions to solve the challenging production requirements. We’ve had no hesitation in appointing SCM Pharma for a repeat project to deliver our product in time for our scheduled Phase III clinical trials." Head of production, Sanofi (UK)